Literature DB >> 22556425

Hypoxia activates tumor suppressor p53 by inducing ATR-Chk1 kinase cascade-mediated phosphorylation and consequent 14-3-3γ inactivation of MDMX protein.

Jun-Ho Lee1, Yetao Jin, Guifen He, Shelya X Zeng, Yunyuan V Wang, Geoffrey M Wahl, Hua Lu.   

Abstract

It has been known that p53 can be induced and activated by hypoxia, an abnormal condition that often occurs in rapidly growing solid tumors or when normal tissues undergo ischemia. Although the ATR-Chk1 kinase cascade was associated with hypoxia-induced p53 activation, molecules that directly link this hypoxia-ATR-Chk1 pathway to p53 activation have been elusive. Here, we showed that hypoxia could induce phosphorylation of MDMX at Ser-367 and enhance the binding of this phosphorylated MDMX to 14-3-3γ, consequently leading to p53 activation. A Chk1 inhibitor or knockdown of ATR and Chk1 inhibited the phosphorylation of MDMX at Ser-367 and impaired the binding of MDMX to 14-3-3γ in addition to p53 activation in response to hypoxia. In primary mouse embryonic fibroblast cells that harbor a mutant MDMX, including the S367A mutation, hypoxia also failed to induce the binding of this mutant MDMX to 14-3-3γ and to activate p53 and its direct targets. These results demonstrate that hypoxia can activate p53 through inactivation of MDMX by the ATR-Chk1-MDMX-14-3-3γ pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556425      PMCID: PMC3375513          DOI: 10.1074/jbc.M111.336875

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.

Authors:  D A Sharp; S A Kratowicz; M J Sank; D L George
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

2.  Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks.

Authors:  K Nakagawa; Y Taya; K Tamai; M Yamaizumi
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  MDM2 suppresses p73 function without promoting p73 degradation.

Authors:  X Zeng; L Chen; C A Jost; R Maya; D Keller; X Wang; W G Kaelin; M Oren; J Chen; H Lu
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 4.  HIF-1 and human disease: one highly involved factor.

Authors:  G L Semenza
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

Review 5.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

6.  Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.

Authors:  Cynthia LeBron; Lihong Chen; Daniele M Gilkes; Jiandong Chen
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

7.  The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo.

Authors:  Lei Huang; Zheng Yan; Xiaodong Liao; Yuan Li; Jie Yang; Zhu-Gang Wang; Yong Zuo; Hidehiko Kawai; Miriam Shadfan; Suthakar Ganapathy; Zhi-Min Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

8.  Enhanced phosphorylation of p53 by ATM in response to DNA damage.

Authors:  S Banin; L Moyal; S Shieh; Y Taya; C W Anderson; L Chessa; N I Smorodinsky; C Prives; Y Reiss; Y Shiloh; Y Ziv
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

Review 9.  Mdmx and Mdm2: brothers in arms?

Authors:  Jean-Christophe Marine; Aart G Jochemsen
Journal:  Cell Cycle       Date:  2004-07-02       Impact factor: 4.534

10.  ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation.

Authors:  Ester M Hammond; Mary Jo Dorie; Amato J Giaccia
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

View more
  12 in total

1.  Tumor suppressor p53 stole the AKT in hypoxia.

Authors:  Zhong Yun; Peter M Glazer
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

2.  Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT.

Authors:  Katarzyna B Leszczynska; Iosifina P Foskolou; Aswin G Abraham; Selvakumar Anbalagan; Céline Tellier; Syed Haider; Paul N Span; Eric E O'Neill; Francesca M Buffa; Ester M Hammond
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

Review 3.  Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.

Authors:  Susan E Scanlon; Peter M Glazer
Journal:  DNA Repair (Amst)       Date:  2015-05-01

4.  AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity.

Authors:  Guifen He; Yi-Wei Zhang; Jun-Ho Lee; Shelya X Zeng; Yunyuan V Wang; Zhijun Luo; X Charlie Dong; Benoit Viollet; Geoffrey M Wahl; Hua Lu
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

5.  Inauhzin sensitizes p53-dependent cytotoxicity and tumor suppression of chemotherapeutic agents.

Authors:  Yiwei Zhang; Qi Zhang; Shelya X Zeng; Qian Hao; Hua Lu
Journal:  Neoplasia       Date:  2013-05       Impact factor: 5.715

6.  Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.

Authors:  Youngjin Han; Boyun Kim; Untack Cho; In Sil Park; Se Ik Kim; Danny N Dhanasekaran; Benjamin K Tsang; Yong Sang Song
Journal:  Oncogene       Date:  2019-08-13       Impact factor: 9.867

7.  Prognostic Gene Expression Signature for Age-Related Hearing Loss.

Authors:  Lu Peng; Nianshen Li; Zhanrong Huang; Chunqin Qiu; Shihua Yin
Journal:  Front Med (Lausanne)       Date:  2022-04-07

8.  Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes.

Authors:  Eran Sadot; Amber L Simpson; Richard K G Do; Mithat Gonen; Jinru Shia; Peter J Allen; Michael I D'Angelica; Ronald P DeMatteo; T Peter Kingham; William R Jarnagin
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 9.  Battle against cancer: an everlasting saga of p53.

Authors:  Qian Hao; William C Cho
Journal:  Int J Mol Sci       Date:  2014-12-01       Impact factor: 5.923

10.  A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia.

Authors:  Daniel E Foxler; Katherine S Bridge; John G Foster; Paul Grevitt; Sean Curry; Kunal M Shah; Kathryn M Davidson; Ai Nagano; Emanuela Gadaleta; Hefin I Rhys; Paul T Kennedy; Miguel A Hermida; Ting-Yu Chang; Peter E Shaw; Louise E Reynolds; Tristan R McKay; Hsei-Wei Wang; Paulo S Ribeiro; Michael J Plevin; Dimitris Lagos; Nicholas R Lemoine; Prabhakar Rajan; Trevor A Graham; Claude Chelala; Kairbaan M Hodivala-Dilke; Ian Spendlove; Tyson V Sharp
Journal:  EMBO Mol Med       Date:  2018-08       Impact factor: 14.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.